Examination of an inducible expression system for limiting iron availability during Chlamydia trachomatis infection

Brian D Dill1, Jane E Raulston

  • 1Department of Microbiology, Box 70579, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614-0579, USA. bddill@yahoo.com

Insights

Overexpressing ferroportin in host cells did not induce Chlamydia trachomatis persistence, unlike iron-chelating drugs. This suggests ferroportin-mediated iron reduction is insufficient to starve the bacteria.

Area of Science:

  • Microbiology
  • Cell Biology
  • Biochemistry

Background:

  • Chlamydia trachomatis requires iron for its life cycle.
  • Iron chelation with Desferal induces bacterial persistence.
  • Ferroportin is a eukaryotic iron efflux protein.

Purpose of the Study:

  • To investigate if inducible ferroportin overexpression can starve Chlamydia trachomatis for iron.
  • To compare ferroportin-mediated iron reduction with Desferal treatment.

Main Methods:

  • Stable transfection of a cell line for inducible ferroportin-green fluorescent protein (Fpn-GFP) expression.
  • Monitoring Fpn-GFP localization and cell viability.
  • Assessing Chlamydia trachomatis infectivity and ferritin levels.

Main Results:

  • Fpn-GFP was detected in the plasma membrane, and cells remained viable.
  • Chlamydial infectivity was unchanged, indicating no induced persistence.
  • Cellular iron reduction by Fpn-GFP was minimal compared to Desferal.

Conclusions:

  • Inducible ferroportin expression does not reduce intracellular iron sufficiently to induce Chlamydia trachomatis persistence.
  • Ferroportin-mediated iron efflux is less effective than Desferal in starving the bacteria.

Related Concept Videos